I came across a couple forum discussions suggesting that increasing the duration of treatment from 12 weeks to 16 or 24 may be beneficial for GT3 patients without cirrhosis. I'm on my last bottles of Dac/Sof (week 10). My data is the following:
GT3a, treatment experienced (interferon + riba), fibroscan - 7.5 (F2),
Pre-treatment (September 2015):
HCV RNA QUANTITATIVE: 2,487,537 IU/mL
ALT(SGPT): 64 U/L (1-53 U/L)
AST (SGOT): 32 U/L (1-50 U/L)
GAMMA GT: 47 U/L (10-54 U/L)
Week 3.5 during treatment (Jan 2016):
HCV RNA QUANTITATIVE: <15 IU/mL
ALT(SGPT): 31 U/L (1-53 U/L)
AST (SGOT): 18 U/L (1-50 U/L)
GAMMA GT: 27 U/L (10-54 U/L)
My doctor is taking it easy, so the next time she wants to see me is one month after the completion of my treatment. She said that there is no point of tests during the treatment other than the week 4 test.
My question is does it make sense to extent my treatment? If so what would be the recommended duration?
I purchased the meds from Mesochem and encapsulated them, back in October last year. However after several appeals the insurance company ended up approving the medication and I have been on the original Dac/Sof. However, I still have the 3 months’ supply from Mesochem in my fridge, so I can’t start taking them if it will increase my chance of getting cured.
Thank you in advance for the reply.